Shares of Theratechnologies Inc. (THTX) are rising over 22% in pre-market today, the company announced new positive results for its investigational Sortilin or SORT1 targeting peptide-drug conjugates, which will be presented in three posters during AACR's virtual annual meeting II on June 22, 2020.
from RTT - Before the Bell https://ift.tt/2LBH74x
via IFTTT
No comments:
Post a Comment